CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56,517 | $101,464 | $122,265 | $136,068 |
| - Cash | $8,586 | $8,196 | $12,945 | $9,408 |
| + Debt | $82,920 | $79,385 | $70,732 | $75,999 |
| Enterprise Value | $130,851 | $172,653 | $180,052 | $202,659 |
| Revenue | $372,809 | $357,776 | $322,467 | $292,111 |
| % Growth | 4.2% | 10.9% | 10.4% | – |
| Gross Profit | $51,401 | $54,431 | $54,502 | $52,120 |
| % Margin | 13.8% | 15.2% | 16.9% | 17.8% |
| EBITDA | $13,683 | $18,197 | $12,347 | $17,526 |
| % Margin | 3.7% | 5.1% | 3.8% | 6% |
| Net Income | $4,614 | $8,344 | $4,311 | $8,001 |
| % Margin | 1.2% | 2.3% | 1.3% | 2.7% |
| EPS Diluted | 3.66 | 6.47 | 3.26 | 5.95 |
| % Growth | -43.4% | 98.5% | -45.2% | – |
| Operating Cash Flow | $9,107 | $13,426 | $16,177 | $18,265 |
| Capital Expenditures | -$2,781 | -$3,031 | -$2,727 | -$2,520 |
| Free Cash Flow | $6,326 | $10,395 | $13,450 | $15,745 |